• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cross Country Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    3/5/25 4:25:16 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary
    Get the next $CCRN alert in real time by email
    ccrn-20250305
    0001141103FALSE00011411032025-03-052025-03-05










    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.  20549
    FORM 8-K
    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


    Date of Report (Date of earliest event reported) March 5, 2025
    Filing - Cross Country full logo_2-2024.jpg
    Cross Country Healthcare, Inc.
    (Exact name of registrant as specified in its charter)

    Delaware
    0-33169
    13-4066229
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)
    6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487
    (Address of Principal Executive Office) (Zip Code)
    (561) 998-2232
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former name or former address, if changed since last report)
    Securities registered pursuant to Section 12(b) of the Act:
        Title of each class                 Trading Symbol         Name of each exchange on which registered
    Common stock, par value $0.0001 per share          CCRN            The Nasdaq Stock Market LLC
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
    Emerging growth company
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.












    Section 2 – Financial Information
    Item 2.02     Results of Operations and Financial Condition
    (a)  On March 5, 2025, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the fourth quarter and full year ended December 31, 2024, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.

    Section 7 – Regulation FD

    Item 7.01    Regulation FD Disclosure.
    Incorporated by reference is a press release issued by the Company on March 5, 2025, which is attached hereto as Exhibit 99.1. This information is being furnished under Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.
    Section 9 – Financial Statements and Exhibits
    Item 9.01    Financial Statements and Exhibits
    (d) Exhibits

    ExhibitDescription
    99.1
    Press Release issued by the Company on March 5, 2025
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)



















































    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

      CROSS COUNTRY HEALTHCARE, INC.
        
        
    Dated:
    March 5, 2025
    By:/s/ William J. Burns
       Name: William J. Burns
       Title: Executive Vice President & Chief Financial Officer
        


    Get the next $CCRN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCRN

    DatePrice TargetRatingAnalyst
    12/10/2024Outperform → Mkt Perform
    Barrington Research
    12/6/2023Mkt Perform
    JMP Securities
    11/3/2023$32.00 → $21.00Buy → Hold
    Jefferies
    6/26/2023Outperform
    William Blair
    3/10/2023$30.00Buy
    Loop Capital
    10/5/2022$36.00Buy → Hold
    Truist
    2/24/2022$33.00 → $42.00Buy
    Benchmark
    1/27/2022$18.00 → $27.00Hold → Buy
    Jefferies
    More analyst ratings